Alumis Inc. (ALMS)
NASDAQ: ALMSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ALMS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $876.28M
- EPS (TTM)
- -$3.86
- Dividend yield
- None
- 52-week range
- 4.28 – 31.35
- Day range
- 6.71 – 6.95
- Volume / Avg
- 2.17M / 2.44M
- Beta
- —
- Shares outstanding
- 129.44M
- Next earnings
- Nov 12, 2026
52-week range
ALMS stock today
On Oct 7, ALMS ended the session at $6.77, shedding $0.16 (2.31%), versus the S&P 500's 0.22% decline. Shares are 78.4% below their 52-week high of $31.35, set on Jul 8, 2026 and 58.4% above the 52-week low of $4.28, near the bottom of the past year's range. ALMS is down 30.6% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 50.1%.
Alumis has posted a net loss over the last twelve months (EPS of -$3.86), so its P/E ratio is not meaningful. Alumis's next earnings report is expected on Nov 12, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Alumis
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2024
Earnings
Earnings history- Next report
- Nov 12, 2026
Alumis peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RIGLRigel Pharmaceuticals Inc. | 47.99 | +4.08% | $896.45M | vs ALMS |
| ANLAdlai Nortye Group Ltd. ADR | 14.05 | -2.84% | $904.79M | vs ALMS |
| CYRXCryoPort Inc. | 17.35 | -2.53% | $878.76M | vs ALMS |
| MLTXMoonLake Immunotherapeutics Class A | 10.77 | -1.64% | $916.60M | vs ALMS |
| JBIOJade Biosciences Inc. | 13.77 | +2.68% | $875.74M | vs ALMS |
| CRVSCorvus Pharmaceuticals Inc. | 10.41 | -1.42% | $875.70M | vs ALMS |
| ANROAlto Neuroscience Inc. | 23.52 | -0.72% | $922.97M | vs ALMS |
| KURAKura Oncology Inc. | 10.67 | +1.33% | $949.21M | vs ALMS |
Indexes, lists and sector
Alumis stock FAQ
What is Alumis's stock price today?
ALMS last traded at $6.77 as of Oct 7, 4:00 PM EDT, down 2.31% on the day. Prices are delayed at least 15 minutes.
When is Alumis's next earnings date?
Alumis is expected to report earnings on Thursday, November 12, 2026.
What is the ALMS 52-week high?
The 52-week high for ALMS is $31.35 and the 52-week low is $4.28. The stock is currently 78.4% below its high.